NEUROPACE, INC. Operating Leases, Rent Expense
NEUROPACE, INC. (NPCE) reported Operating Leases, Rent Expense of $700.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2023-03-02
- NEUROPACE, INC. operating leases, rent expense for the quarter ending 2022-03-31 was $700.00K, a 0.00% change year-over-year.
- NEUROPACE, INC. operating leases, rent expense for the quarter ending 2021-12-31 was $700.00K, a 0.00% change year-over-year.
- NEUROPACE, INC. operating leases, rent expense for the quarter ending 2021-09-30 was $700.00K, a 0.00% change year-over-year.
- NEUROPACE, INC. operating leases, rent expense for the quarter ending 2021-06-30 was $700.00K, a 0.00% change year-over-year.
- NEUROPACE, INC. operating leases, rent expense for fiscal 2021 was $2.80M, a 3.70% increase from fiscal 2020.
- NEUROPACE, INC. operating leases, rent expense for fiscal 2020 was $2.70M.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|---|
| 2022-03-31 | $700.00K 10-Q · filed 2022-05-12 | $1.40M derived: sum of 2 quarters · filed 2023-03-02 | $2.10M derived: sum of 3 quarters · filed 2023-03-02 | $2.80M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $1.40M derived: sum of 2 quarters · filed 2023-03-02 | $2.10M derived: sum of 3 quarters · filed 2023-03-02 | $2.80M 10-K · filed 2023-03-02 |
| 2021-09-30 | $700.00K 10-Q · filed 2022-11-08 | $1.40M derived: sum of 2 quarters · filed 2022-11-08 | $2.10M 10-Q · filed 2022-11-08 | $2.80M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $700.00K 10-Q · filed 2022-08-11 | $1.40M 10-Q · filed 2022-08-11 | $2.10M derived: sum of 3 quarters · filed 2022-08-11 | $2.80M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $700.00K 10-Q · filed 2021-06-03 | $1.40M derived: sum of 2 quarters · filed 2022-03-10 | $2.10M derived: sum of 3 quarters · filed 2022-03-10 | $2.80M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $1.40M derived: sum of 2 quarters · filed 2022-03-10 | $2.10M derived: sum of 3 quarters · filed 2022-03-10 | $2.70M 10-K · filed 2022-03-10 |
| 2020-09-30 | $700.00K 10-Q · filed 2021-11-10 | $1.40M derived: sum of 2 quarters · filed 2021-11-10 | $2.00M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $700.00K 10-Q · filed 2021-08-12 | $1.30M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $700.00K 10-Q · filed 2021-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |